Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.

about

Downregulations of AKT/mTOR Signaling Pathway for Salmonella-Mediated Suppression of Matrix Metalloproteinases-9 Expression in Mouse Tumor Models.Attenuated Bacteria as Immunotherapeutic Tools for Cancer Treatment.

P2860

Q54977376-A8C31F7D-A09C-480B-8B5A-84C33C7EA845 Q55025711-7EED28C1-072D-43DC-9923-CA3F4611D3E7

P2860

Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.

Item

http://www.wikidata.org/entity/Q47195461

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Engineered Salmonella enterica ...... cteria-mediated tumor therapy.

@en

Engineered Salmonella enterica ...... cteria-mediated tumor therapy.

@nl

type

Item

label

Engineered Salmonella enterica ...... cteria-mediated tumor therapy.

@en

Engineered Salmonella enterica ...... cteria-mediated tumor therapy.

@nl

prefLabel

Engineered Salmonella enterica ...... cteria-mediated tumor therapy.

@en

Engineered Salmonella enterica ...... cteria-mediated tumor therapy.

@nl

P1476

Engineered Salmonella enterica ...... cteria-mediated tumor therapy.

@en

P2093

Christine Falk

http://www.w3.org/2001/XMLSchema#string

Dino Kocijancic

http://www.w3.org/2001/XMLSchema#string

Kurt Zimmermann

http://www.w3.org/2001/XMLSchema#string

Manfred Rohde

http://www.w3.org/2001/XMLSchema#string

Michael Frahm

http://www.w3.org/2001/XMLSchema#string

Sebastian Felgner

http://www.w3.org/2001/XMLSchema#string

Siegfried Weiss

http://www.w3.org/2001/XMLSchema#string

Ulrike Heise

http://www.w3.org/2001/XMLSchema#string

P2860

The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex

The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy

Bacteria in Cancer Therapy: Renaissance of an Old Concept

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma.

Tumor invasion of Salmonella enterica serovar Typhimurium is accompanied by strong hemorrhage promoted by TNF-alpha

Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium.

A Salmonella nanoparticle mimic overcomes multidrug resistance in tumours.

Bacterial nanomachines: the flagellum and type III injectisome.

Modulating the innate immune response by combinatorial engineering of endotoxin

Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system

P304

e1382791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2017.1382791

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marc Erhardt

P577

2017-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29308303

http://www.w3.org/2001/XMLSchema#string

P921

Salmonella enterica

P932

5749626

http://www.w3.org/2001/XMLSchema#string

Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.

about

P2860

P2860

Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932